New Synthetic Quinolines as Cathepsin K Inhibitors
AUTOR(ES)
Silva, Taynara L.; Bartolomeu, Aloisio de A.; Jesus, Hugo C. R. de; Oliveira, Kleber T. de; Fernandes, João B.; Brömme, Dieter; Vieira, Paulo C.
FONTE
J. Braz. Chem. Soc.
DATA DE PUBLICAÇÃO
2020-08
RESUMO
Cathepsin K is a papain-like cysteine protease and is responsible for collagen degradation in bone tissue and thus represents an important target for the development of new therapies for treating diseases such as osteoporosis. Quinolines are an important class of heterocyclic molecular leads with a great pharmacological potential and represent a relevant scaffold to explore the chemical space of cathepsin K (CatK) inhibitors. This study presents the synthesis of nine 2,4-diphenylquinolines, including five phthalonitrile quinolines dyads, and the evaluation of their CatK inhibitory activity. Among the evaluated compounds, 4b was the most potent inhibitor with an IC50 (half-maximal inhibitory concentration) value of 1.55 µM (against Z-Phe-Arg-MCA substrate) acting in an uncompetitive inhibition mode. Molecular docking studies provided important information on the interaction of the inhibitor with the enzyme showing that these quinoline derivatives can play an important role as CatK inhibitors.
Documentos Relacionados
- Design of potent and selective human cathepsin K inhibitors that span the active site
- A New Class of Synthetic Auxin Transport Inhibitors 1
- Synthetic peptides as substrates and inhibitors of a retroviral protease.
- Alkylguanidines as Inhibitors of K+ Transport in Isolated Barley Roots
- Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity.